About Biofortuna
Biofortuna is a company based in Birkenhead (United Kingdom) founded in 2008 by Katherine Douglas, Nanette Douglas, and Rachel Douglas.. Biofortuna has raised $21.58 million across 8 funding rounds from investors including Enterprise Ventures, Foresight Group and Merseyside Special Investment Fund. The company has 32 employees as of March 31, 2022. Biofortuna has completed 1 acquisition, including Cryoniss. Biofortuna operates in a competitive market with competitors including Novartis, Catalent, Surrozen, Biotage and Curia, among others.
- Headquarter Birkenhead, United Kingdom
- Employees 32 as on 31 Mar, 2022
- Founders Katherine Douglas, Nanette Douglas, Rachel Douglas
- Stage Minicorn
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Biofortuna Limited
- Date of Incorporation 26 Feb, 2008
- Jurisdiction DEESIDE, WALES
-
Annual Revenue
$1.44 M (USD)-12as on Mar 31, 2018
-
Net Profit
$-1.34 M (USD)-32as on Mar 31, 2018
-
EBITDA
$-1.57 M (USD)-17as on Mar 31, 2018
-
Total Equity Funding
$21.58 M (USD)
in 8 rounds
-
Latest Funding Round
-
Investors
Enterprise Ventures
& 4 more
-
Employee Count
32
as on Mar 31, 2022
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Biofortuna
Biofortuna has successfully raised a total of $21.58M across 8 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 8
- Last Round Last Round
-
First Round
First Round
(11 May 2010)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2021 | Amount | Series A - Biofortuna | Valuation |
investors |
|
| Aug, 2018 | Amount | Series A - Biofortuna | Valuation |
investors |
|
| Jul, 2017 | Amount | Series A - Biofortuna | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Biofortuna
Biofortuna has secured backing from 5 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Enterprise Ventures, Foresight Group and Merseyside Special Investment Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A fund focused on supporting SMEs with alternative finance.
|
Founded Year | Domain | Location | |
|
Early and Growth stage Venture Debt firm that does debt investments in the UK
|
Founded Year | Domain | Location | |
|
Investment solutions are provided by Catapult Ventures for growth.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Biofortuna
Biofortuna has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Cryoniss. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provider of biobanking services for life sciences industries
|
2018 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Biofortuna
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biofortuna Comparisons
Competitors of Biofortuna
Biofortuna operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Novartis, Catalent, Surrozen, Biotage and Curia, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
R&D focused on manufacturing of drugs for multiple therapeutic areas
|
|
| domain | founded_year | HQ Location |
CDMO offering drug and biologics development services
|
|
| domain | founded_year | HQ Location |
Selective Wnt agonists are developed for human tissue regeneration.
|
|
| domain | founded_year | HQ Location |
Organic synthesis, analytical, and peptide chemistry services for drug discovery and development
|
|
| domain | founded_year | HQ Location |
Drug research, development, testing, and consulting services are provided.
|
|
| domain | founded_year | HQ Location |
Protein therapeutics are developed and manufactured by WuXi Biologics.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Biofortuna
Frequently Asked Questions about Biofortuna
When was Biofortuna founded?
Biofortuna was founded in 2008 and raised its 1st funding round 2 years after it was founded.
Where is Biofortuna located?
Biofortuna is headquartered in Birkenhead, United Kingdom. It is registered at Birkenhead, Merseyside, United Kingdom.
Is Biofortuna a funded company?
Biofortuna is a funded company, having raised a total of $21.58M across 8 funding rounds to date. The company's 1st funding round was a Series A of $2.09M, raised on May 11, 2010.
How many employees does Biofortuna have?
As of Mar 31, 2022, the latest employee count at Biofortuna is 32.
What is the annual revenue of Biofortuna?
Annual revenue of Biofortuna is $1.44M as on Mar 31, 2018.
What does Biofortuna do?
Biofortuna was established in 2008 in Birkenhead, United Kingdom, within the biotechnology sector. Operations focus on contract manufacturing for immunoassays and molecular diagnostics, complemented by regulatory services. These activities support diagnostic product development and compliance needs for clients in healthcare and life sciences. The company is led by co-founders Katherine Douglas, Nanette Douglas, and Rachel Douglas.
Who are the top competitors of Biofortuna?
How many acquisitions has Biofortuna made?
Biofortuna has made 1 acquisition, including Cryoniss.
Who are Biofortuna's investors?
Biofortuna has 5 investors. Key investors include Enterprise Ventures, Foresight Group, Merseyside Special Investment Fund, Catapult Ventures, and David Whitcombe.
What is Biofortuna's valuation?
The valuation of Biofortuna is $476.6M as of Aug 2018.